当前位置:首页 > 文献互助 > 互助详情

A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes复制

用户9NZbZXxY_fOE 6小时前 10 10 求助中 帖子自动结束时间: 2025-07-02 16:20:11

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性,不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接: https://pubmed.ncbi.nlm.nih.gov/21510461复制

其他信息:

PMID: 21510461
作者: S Jayaram; R S Hariharan; R Madhavan; I Periyandavar; S S Samra; ...
摘要: Objective: The present study was a prospective, parallel group, open-labeled, comparative, multicentric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetic patients.

互助时间线

2025-06-27 16:20:11 [发起求助]

最新发布的求助